EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elimination of lymphatic filariasis as a public health problem in Malawi

John Chiphwanya, Square Mkwanda, Storn Kabuluzi, Themba Mzilahowa, Bagrey Ngwira, Dorothy E Matipula, Limbikani Chaponda, Paul Ndhlova, Prince Katchika, Chawananga Mahebere Chirambo, Philemon Moses, Justin Kumala und 15 weitere

PLOS Neglected Tropical Diseases · 16.02.2024 · 18 (2) · e0011957

DOI: 10.1371/journal.pntd.0011957 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 16.02.2024. Verfasst von John Chiphwanya und 26 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Health, Lilongwe, Malawi. Hauptthemen laut MEDLINE: Elephantiasis, Filarial, Anopheles, Malaria, Lymphedema. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, Foreign, Commonwealth and Development Office, GlaxoSmithKline.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lymphatic filariasis (LF) is a parasitic disease transmitted by mosquitoes, causing severe pain, disfiguring, and disabling clinical conditions such as lymphoedema and hydrocoele. LF is a global public health problem affecting 72 countries, primarily in Africa and Asia. Since 2000, the World Health Organization (WHO) has led the Global Programme to Eliminate Lymphatic Filariasis (GPELF) to support all endemic regions. This paper focuses on the achievements of the Malawi LF Elimination Programme between 2000 and 2020 to eliminate LF as a public health problem, making it the second sub-Saharan country to receive validation from the WHO. Methodology/principal findings The Malawi LF Programme addressed the widespread prevalence of LF infection and disease across the country, using the recommended WHO GPELF strategies and operational research initiatives in collaboration with key national and international partners. First, to stop the spread of infection (i.e., interrupt transmission) and reduce the circulating filarial antigen prevalence from as high as 74.4% to below the critical threshold of 1–2% prevalence, mass drug administration (MDA) using a two-drug regime was implemented at high coverage rates (>65%) of the total population, with supplementary interventions from other programmes (e.g., malaria vector control). The decline in prevalence was monitored and confirmed over time using several impact assessment and post-treatment surveillance tools including the standard sentinel site, spot check, and transmission assessment surveys and alternative integrated, hotspot, and easy-access group surveys. Second, to alleviate suffering of the affected populations (i.e., control morbidity) the morbidity management and disability prevention (MMDP) package of care was implemented. Specifically, clinical case estimates were obtained via house-to-house patient searching activities; health personnel and patients were trained in self-care protocols for lymphoedema and/or referrals to hospitals for hydrocoele surgery; and the readiness and quality of treatment and services were assessed with new survey tools.

Conclusions

Malawi’s elimination of LF will ensure that future generations are not infected and suffer from the disfiguring and disabling disease. However, it will be critical that the Malawi LF Elimination programme remains vigilant, focussing on post-elimination surveillance and MMDP implementation and integration into routine health systems to support long-term sustainability and ongoing success. Summary Lymphatic filariasis, also known as elephantiasis, is a disabling, disfiguring, and painful disease caused by a parasite that infected mosquitoes transmit to millions of people worldwide. Since 2000, the Global Programme to Eliminate Lymphatic Filariasis (GPELF) has supported endemic countries such as Malawi in south-eastern Africa, to eliminate the disease as a public health problem. The Malawi National LF Elimination Programme has worked tirelessly over the past two decades to implement the GPELF recommended strategies to interrupt the transmission with a two-drug regime, and to alleviate suffering in patients with lymphoedema and/or hydrocoele through morbidity management and disability prevention. Additionally, the LF Programme has collaborated with national and international stakeholders to implement a range of supplementary operational research projects to address outstanding knowledge gaps and programmatic barriers. In 2020, the World Health Organisation validated that Malawi had successfully eliminated LF as a public health problem, making it the second country in sub-Saharan Africa to achieve this, which is remarkable given that Malawi previously had very high infection rates. The LF Programme now remains vigilant, putting its efforts towards post-elimination surveillance and the continued implementation of care for patients with chronic conditions. Malawi’s elimination of LF will ensure that future generations are not affected by this devastating disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Elephantiasis, FilarialAnophelesMalariaLymphedemaAnimalsHumansPublic HealthMalawiMosquito VectorsBlindness

Autor:innen und Institutionen

  • Ministry of Health, Lilongwe, Malawi.
  • Malaria Alert Centre, Kamuzu University of Health Sciences, Blantyre, Malawi.
  • Centre for Health, Agriculture, Development Research, and Consulting, Blantyre, Malawi.
  • Centre for Neglected Tropical Diseases, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
  • World Health Organization, Geneva, Switzerland.
  • Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

ORCID-Profile: Louise A Kelly-Hope

Förderung

  • World Health Organization
  • Foreign, Commonwealth and Development Office
  • GlaxoSmithKline
  • The Medical Research Council
  • Coalition for Operational Research for Neglected Tropical Diseases

Zitieren

APA

Chiphwanya, J., Mkwanda, S., Kabuluzi, S., Mzilahowa, T., Ngwira, B., Matipula, D. E., Chaponda, L., Ndhlova, P., Katchika, P., Mahebere Chirambo, C., Moses, P., Kumala, J., Chiumia, M., Barrett, C., Betts, H., Fahy, J., Rebollo Polo, M., Reimer, L., Stanton, M. C., …, & Kelly-Hope, L. A. (2024). Elimination of lymphatic filariasis as a public health problem in Malawi. PLOS Neglected Tropical Diseases, 18(2), e0011957. https://doi.org/10.1371/journal.pntd.0011957

Vancouver

Chiphwanya J, Mkwanda S, Kabuluzi S, Mzilahowa T, Ngwira B, Matipula DE, et al. Elimination of lymphatic filariasis as a public health problem in Malawi. PLOS Neglected Tropical Diseases. 2024;18(2):e0011957. doi:10.1371/journal.pntd.0011957

BibTeX
@article{Chiphwanya2024,
  author = {Chiphwanya, John and Mkwanda, Square and Kabuluzi, Storn and Mzilahowa, Themba and Ngwira, Bagrey and Matipula, Dorothy E and Chaponda, Limbikani and Ndhlova, Paul and Katchika, Prince and Mahebere Chirambo, Chawananga and Moses, Philemon and Kumala, Justin and Chiumia, Martin and Barrett, Carrie and Betts, Hannah and Fahy, Joan and Rebollo Polo, Maria and Reimer, Lisa and Stanton, Michelle C and Thomas, Brent and Freer, Sian and Molyneux, David H and Bockarie, Moses J and Mackenzie, Charles D and Taylor, Mark J and Martindale, Sarah and Kelly-Hope, Louise A},
  title = {Elimination of lymphatic filariasis as a public health problem in Malawi},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  volume = {18},
  number = {2},
  pages = {e0011957},
  doi = {10.1371/journal.pntd.0011957}
}
Kostenlos starten →